Eye preparations, including a brain-derived nerve transfer factor (BDNF) at a concentration of at least 15 micrograms/micrograms, can be used to prevent and/or treat retinal neurodegenerative diseases, optical nerves and lateral genomes.

摘要

THE PRESENT INVENTION REFERRED TO AN OFFICIAL PREPARATION, LICENSE IN THE FORM OF EYE DROPS THAT INCLUDES A NEUROTROAcute FACTOR; DERIVED PHICO DO BRAIN (BDNF) WAS A CONCENTRATION OF AT LEAST 15 PG / IL, AND A SOLUTION; NV (SCOSIFLCADA AS A PHARMACEUTICAL POWDER THAT UNDERSTANDS POLISACAacute; EXTRAIATE RIDO; DO OF SEEDS OF TAMARINDO CONCERNING); WHICH WOULD VARY FROM 0.05 TO 2 emPLV, / IN WHICH IT IS USEFUL FOR PREVENTION, NY / OR PROCESSING OF NEURODEGENERATIVE DISEASES OF THE RETINA,Oacute; optics and skeletal anaphase; / P